These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26237606)

  • 21. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Alzheimer's disease modelling using induced pluripotent stem cell technology.
    Mohamet L; Miazga NJ; Ward CM
    World J Stem Cells; 2014 Apr; 6(2):239-47. PubMed ID: 24772250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.
    Watson LM; Wong MM; Becker EB
    Open Biol; 2015 Jul; 5(7):150056. PubMed ID: 26136256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling.
    de Leeuw S; Tackenberg C
    Transl Neurodegener; 2019; 8():21. PubMed ID: 31338163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
    Pen AE; Jensen UB
    Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Present and future challenges of induced pluripotent stem cells.
    Ohnuki M; Takahashi K
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.
    Qiang L; Fujita R; Abeliovich A
    Neuron; 2013 Jun; 78(6):957-69. PubMed ID: 23791192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
    Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
    Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
    Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality.
    Strässler ET; Aalto-Setälä K; Kiamehr M; Landmesser U; Kränkel N
    Front Cardiovasc Med; 2018; 5():4. PubMed ID: 29423397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
    Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
    Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
    van Hugte E; Nadif Kasri N
    Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Representing Diversity in the Dish: Using Patient-Derived
    Ghaffari LT; Starr A; Nelson AT; Sattler R
    Front Neurosci; 2018; 12():56. PubMed ID: 29479303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Three-Dimensional Alzheimer's Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1.
    Hernández-Sapiéns MA; Reza-Zaldívar EE; Cevallos RR; Márquez-Aguirre AL; Gazarian K; Canales-Aguirre AA
    Front Cell Neurosci; 2020; 14():151. PubMed ID: 32655369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.